欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/1244/002
药品名称Zanipress 20 mg/10 mg
活性成分
    • enalaprilat maleate 20.0 mg
    • lercanidipine hydrochloride 10.0 mg
剂型Film-coated tablet
上市许可持有人Recordati S.p.A. Industria Chimica e Farmaceutica Via Matteo Civitali 1 20148 Milano Italy
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Zanipril 20 mg/10 mg Filmtabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
      Zaneril
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Lercaprel 20 mg/10 mg
    • Estonia (EE)
      LERCARIL
    • Bulgaria (BG)
      Lercapril
    • Cyprus (CY)
      ZANIPRESS 10MG/20MG
    • Romania (RO)
      Lercaril 20mg/10mg
    • Slovenia (SI)
    • Malta (MT)
      Zanipress 10mg/20mg film-coated Tablets
    • Netherlands (NL)
许可日期2008/03/11
最近更新日期2023/09/25
药物ATC编码
    • C09BB02 enalapril and lercanidipine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase